Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Shield Therapeutics PLC on Tuesday said it has now completed its USD20 million senior secured debt facility from SWK ...
Shield Therapeutics PLC 03 October 2023 3 October 2023 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR...
Shield Therapeutics PLC 03 October 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Block...
Shield Therapeutics PLC on Thursday announced steps to improve its financial situation, as it revealed a slightly red ...
Shield Therapeutics PLC 28 September 2023 28 September 2023 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR...
Shield Therapeutics PLC 28 September 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR...
Shield Therapeutics PLC 28 September 2023 THIS ANNOUNCEMENT (INCLUDING THE APPICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT...
Shield Therapeutics PLC 28 September 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Interim...
cs PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of it ...
Shield Therapeutics PLC 06 September 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Notice...
ame of Sage Therapeutics Inc. Please ignore incorrect coding of Shield Therapeutics PLC.) (Alliance News) - The US Fo ...
The US Food & Drug Administration has approved Zurzuvae, zuranolone, 50 mg for adults with postpartum depression, Sag ...
Shield Therapeutics PLC 24 July 2023 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYV81293 Issuer Name SHIELD...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지